Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3276448 A
Publication typeGrant
Publication dateOct 4, 1966
Filing dateDec 14, 1962
Priority dateDec 14, 1962
Publication numberUS 3276448 A, US 3276448A, US-A-3276448, US3276448 A, US3276448A
InventorsRichard L Kronenthal
Original AssigneeEthicon Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Collagen coated fabric prosthesis
US 3276448 A
Images(3)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent 3,276,448 COLLAGEN COATED FABRIC PROSTHESIS Richard L. Kronenthal, Fair Lawn, N.J., assiguor to Ethicon, Inc., Somerville, N.J., a corporation of New Jersey No Drawing. Filed Dec. 14, 1962, Ser. No. 244,600 4 Claims. (Cl. 128-334) This invention relates to prostheses adapted to be placed in the human body, and to a process for manufacturing the same. More particularly, the invention is directed to prostheses formed of porous, non-absorbable fabric coated with collagen.

For purposes of clarity, the terms used herein are defined as follows:

Tendon collagen fibril means a thread-like collagen structure derived from beef tendon that is round in cross section. These fibrils in the completely dehydrated state measure about 500 to 2000 Angstroms in diameter.

Swollen tendon collagen fibril means a collagen fibril derived from beef tendon that has been swollen in acid solution. The diameters of swollen collagen fibrils range from less than 5000 Angstroms to about 90,000 Angstroms.

Monofilament means a single thread of oriented collagen fibrils as extruded through a single orifice in a spinnerette.

Multifilament means a group :of individual separate collagen monofilaments extruded through a spinnerette. Further details are provided in related copending application Serial No. 216,247, filed August 10, 1962, and in Example XII of U.S. Patent No. 3,114,372.

Strand means a group of collagen monofilaments that have been united to form a unitary structure.

Tape means a group of individual collagen monofilaments that have been united to form a unitary structure that is ribbon-like in shape.

Non-absorbable fibers means those fibers, synthetic or natural, which are not absorbed in an animal body, particularly a human body, when present therein over an extended period of time. A non-absorbable fabric is a fabric formed of non-absorbable fibers.

Associations of collagen and non-absorbable fibers means a combination of collagen filaments or strands and one or more non-absorbable fibers, formed by iweaving, knitting, braiding, crocheting, etc. the filaments or strands and fibers together into articles including tubes, which can be straight or Y-shaped.

In the surgical repair of hernias, tantalum gauze and inert fabrics have found considerable use, particularly in older patients who are recognized to have a reduced ability to rebuild tissue at the point of surgery. Tantalum gauze, however, has the undesirable property of work hardening and can curl up within the body, causing discomfort. Inert fabric prostheses have the disadvantage that they do not become a part of the body tissue. During surgery, some surgeons have tried to overcome this disadvantage by knotting catgut sutures randomly throughout the fabric prosthesis. However, this does not result in a uniformly integrated fabric prosthesis. Many intert fabric inserts frequently remain surrounded by a pool of sera after the healing process. A suitable prosthesis for strengthening the repair should be non-toxic, flexible and porous. The ideal prosthesis should retain its strength permanently in intimate contact with body fluids and should be readily accepted and incorporated into the tissues. Porosity is an important characteristic of such a prosthesis to avoid the formation of fluid pockets and to promote the growth through the fabric of repair tissue.

3,276,448 Patented Oct. 4, 1966 A primary object of the invention, therefore, is to provide a porous, non-absorbable fabric compatible with an animal body, and coated with collagen. A further object is to provide a porous, non-absorbable fabric which is coated with collagen and the pores of which are free of collagen. Another object is the provision of prostheses comprised of the fabric so coated with collagen and promoting the growth of body tissue into and through the prostheses during the healing process.

Still another object is the provision of a process for manufacturing the prostheses of this invention. And another object is the provision of a process for pretreating the fabric in the manufacture of the prostheses.

Additional objects will be apparent from the following discussion.

The foregoing objects are realized with an improved prostheses comprised of a porous, non-absorbable fabric coated with collagen, the pores of the fabric being free of collagen. It is an essential feature of the new prostheses that the pores thereof are open and not rendered blood tight by collagen fibrils. In this regard, they are distinct fromthose described by Artandi and Bechtol in related application Serial No. 92,620, filed March 1, 1961 (now abandoned), and application Serial No. 495,010 filed September 22, 1965.

The prostheses of this invention are formed by knitting, weaving, braiding, crocheting, etc. non-absorbable fibers into the shape or form desired. The fibers are not absorbed by an animal body, as the human body, when present therein over extended time intervals, such as a decade. Examples of suitable materials are Vinyon-N, a resin manufactured by the Carbide and Carbon Corporation by copolymerizing vinyl chloride and acrylonitrile; Saran, a vinyl chloride polymer manufactured by the Dow Chemical Company; nylon, a polyamide resin made by polymerization of the hexamethylene diamine salt of adipic acid; Orlon, a synthetic fiber made from polyacrylonitrile; Dacron, a synthetic fiber made from terephthalic acid and ethylene glycol; Teflon, a tetrafluoroethylene polymer; polyolefins such as polyethylene and polypropylene; cotton and silk. Nylon, Orlon, Dacron and Teflon are products of the E. I. du Pont de Nemours 8: Co. Preferred herein are Dacron, Teflon and polyolefins.

It is to be understood that the non-absorbable fibers used herein can be knitted, woven, braided, crocheted, etc. into forms suitable for porous implants, in any manner known in the art, since such does not form a part of this invention.

Collagen used herein to coat the non-absorbable fabric corresponds to the type of connective tissue normally laid down by the body during the healing process. Thus, the collagen coating serves as a stimulus for body response during the post-operative period. The porous character of the fabric allows for rapid in-growth of fibroblasts and endothelial cells. All such features combine in concert to make possible rapid and satisfactory attachment of the prosthesis to the host tissues.

Collagen can be prepared as described in United States Patent No. 2,920,000 of H. R. Hoohstadt and E. R. Lieberman. Since it is diflicult to prepare a collagen dispersion containing more than 2 percent collagen because of ex tremely high viscosities of more concentrated dispersions, the collagen dispersions used in this invention generally contain from 0.1 to 2 percent by weight of collagen. The vehicle or liquid containing collagen can be one of a wide variety of materials, including: alcohols such as methanol; aqueous solutions of perfluoroacids, as shown in US. Patent Nos. 2,919,998 and 2,919,999; and aqueous cyanoacetic acid. Particularly preferred herein are collagen dispersions in a mixture of methanol and aqueous cyanoacetic acid.

The non-absorbable fabric, as in film or mesh form, can be coated with collagen by a number of techniques. The fabric can be immersed in a collagen dispersion for a suitable period of time, and the fabric can then be removed and allowed to drain and dry. Collagen is neutralized after the coated fabric is dry. Alternatively, a dispersion of collagen can be sprayed onto the fabric, followed by draining of the sprayed fabric.

When the fabric is immersed in a collagen dispersion, the fabric is coated with collagen and is thereafter treated to remove collagen present in the pores thereof. This is accomplished advantageously by directing a stream of inert gas against the coated fabric, particularly through the coated fabric. The stream is so adjusted that collagen held in the pores of the coated fabric is removed, while collagen coating the fabric structure is retained. There is little danger that the collagen coat will be removed from the fabric, since a relatively strong bonding of collagen and the fabric obtains. Representative of inert gases useful herein are air, nitrogen, and carbon dioxide. Since air is inexpensive and advantageous, it is preferred.

Still other techniques can be used herein. A fabric treated with collagen can be dried and then perforated to remove collagen from the pores thereof.

Temperatures of the impregnation step, draining (if such is used), neutralization and removal of collagen from the pores, are generally below about C. in each operation to avoid extensive degradation of collagen. Preferred for each operation are temperatures below about 25 C.

It is to be understood that any of the known tanning agents for use with collagen can be used herein. Chromium, formaldehyde, polyhydroxyphenols, etc. can be used alone or in combination. Particularly preferred, however, are the tanning procedures described in related applications Serial Numbers 85,289 and 85,302, both filed January 27, 1961.

In conjunction with the process for coating a nonabsorbable fabric with collagen, it has been discovered that a firmer bonding of collagen and the fabric results when the fabric is pretreated. The pretreatment involves successive contact with a solvent (A) for hydrophilic materials and a solvent (B) for hydrophobic materials. Solvents (A) and (B) are those which do not dissolve or attack the fiber. Solvents falling within category (A) include water and dilute aqueous solutions containing a detergent, among which are sulfates such as sodium lauryl sulfate, sulfonates such as sodium dodecyl benzene sulfonate, phosphates such as sodium tripolyphosphate, polyoxyalkylene derivatives of a hydroxy compound such as a condensate of 1 mol of nonyl phenol with 9 mols of ethylene oxide, quarternary ammonium compounds such as cetyltrimethylammonium chloride, etc. Representative of solvents (B) are: alcohols, typified by methyl, ethyl, n-propyl, isopropyl, n-butyl, secondaryand tertiary-butyl, etc.; ketones, typified by acetone, methyl ethyl, methyl n-propyl, diethyl, etc.; ethers, typified by dimethyl, diethyl, ethyl methyl, etc. Generally, a large excess of one or more solvents (A) and of one or more solvents (B), is used in the pretreatment of a non-adsorbable fiber. Pretreatment is conducted at temperatures from about C. to about 100 C., for time intervals ranging from about 60 minutes to about 1 minute with each solvent, (A) and (B); preferred conditions are the approximate ranges of 6070 C., for 10-5 minutes.

The present invention is more fully described and exemplified in the following examples. It is to be understood, however, that my invention is not to be limited to any specific form or materials or construction set forth in the examples, but is limited solely by the description in this Specification and the appended claims. Throughout the Specification and the examples which follow, all

quantities are expressed in parts by weight unless otherwise indicated.

Example I 4.33 grams of Dacron mesh (40 denier multifilament Dacron 12.5 inch square) was immersed in a gel prepared by diluting a collagen dispersion comprising 0.8 part of collagen, 0.4 part cyanoacetic acid, 49.4 parts water and 49.4 parts of methyl alcohol with an equal volume of methyl alcohol at room temperature (20 C.). The mesh was removed from the dispersion and allowed to drain vertically for about five minutes at room temperature. Compressed air was blown through the mesh to remove any collagenous film remaining across the interstices. If the orifice pressure is about 20 lbs. and the orifice is 4 mm. in diameter, a distance of approximately 3" between the orifice and the mesh is advantageous. Using the same orifice at 35 lbs. pressure, approximately 12" is advantageous between the orifice and the mesh. Shorter distances or higher pressures were found to blow too much collagen from the mesh while longer distances and lower pressures did not completely remove the collagen dispersion from the interstices. The mesh was allowed to dry for several hours at room temperature. The collagen on the mesh fabric was then neutralized with parts of 10% aqueous ammonia and was tanned with 100 parts formaldehyde (1% aqueous solution). Mesh, so obtained, contains approximately 10% by weight of collagen on the surface of the Dacron fibers. When implanted in the subcutaneous tissue of rats, the coated mesh elicited a greater amount of tissue response and fibroplasia than the uncoated mesh and was more readily incorporated by the host tissue.

Example II A piece of Dacron mesh (the same size and Weight as in Example I) was washed successively with 100 parts of hot water (60 C.), with 100 parts of isopropyl alcohol (25 C.) and 100 parts of acetone (25 C.). It was then dried in the air. The dried mesh was placed in a stainless-steel, Teflon coated tray measuring 15" x 9" x /2" containing a A;" layer of collagen dispersion containing 0.8 part of collagen fibrils and 49.4 parts of methyl alcohol, and 49.4 parts of water and 0.4 part of cyanoacetic acid, and another A2" layer of the same dispersion was placed on top of the fabric. The collagen dispersions and mesh were in contact for 24 hours at 25 C. The resulting laminate then was neutralized with 100 parts of 10 percent aqueous ammonia. It was tanned with 100 parts of formaldehyde (1 percent) and removed from the tray. Edges of the mesh were trimmed to remove excess collagen. The laminate was strong, uniform and very resistant to separation. These characteristics continued when the film was wet with water. Only very severe stretching or deformation freed an edge of the collagen from the Dacron mesh and, once freed, it resisted further delarnination.

It is found that Dacron and collagen are more firmly bound by virtue of the pretreatment of Dacron, than when the pretreatment is omitted. In fact, pretreated Dacron and collagen are more firmly bound than when brought together by any other technique.

While the invention has been described in detail according to the articles and manufacture thereof, it is to be understood that changes and modifications can be made (without departing from the spirit or scope of the invention) and it is intended in the appended claims to cover such changes and modifications.

I claim:

1. A surgical prosthesis comprising:

a porous fabric of non-absorbable interlocking fibers;

said fibers being coated with collagen fibrils throughout their area of contact only, whereby the pores 5 of the fabric are open to the rapid ingrowth of body tissue through the prosthesis.

2. The surgical prosthesis of claim 1 wherein the porous fabric is tubular in form.

3. The surgical prosthesis of claim 1 wherein the porous fabric is a synthetic material made from terephthalic acid and ethylene glycol.

4. The surgical prosthesis of claim 1 wherein the porous fabric is a synthetic material made of a tetrafluoroethylene polymer.

References Cited by the Examiner UNITED STATES PATENTS RICHARD A. GAUDET, Primary Examiner.

DALTON L. TRULUCK, Examiner.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US1514548 *Sep 10, 1921Nov 4, 1924Ernest LionnePorous impregnated fabric
US2039262 *Feb 7, 1934Apr 28, 1936Koninklijke Pharma Fab NvProcess for the manufacture of threads, strings, bands, films, and the like
US2305006 *Feb 8, 1939Dec 15, 1942Robert S HoltMethod of delustering textile material and resulting product
US3106483 *Jul 27, 1961Oct 8, 1963Us Catheter & Instr CorpSynthetic blood vessel grafts
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3366440 *Nov 3, 1964Jan 30, 1968Ethicon IncProcess for manufacturing a collagen fabric-film laminate
US3400719 *Jun 9, 1964Sep 10, 1968Albert O.L.J. Eckhart BuddeckePlastic graft material and method of making same
US3443261 *Sep 1, 1967May 13, 1969Fmc CorpProsthetic structures from microcrystalline collagen
US3463158 *Jan 9, 1967Aug 26, 1969American Cyanamid CoPolyglycolic acid prosthetic devices
US3649347 *Apr 27, 1970Mar 14, 1972Fmc CorpShaped structures having a self-adherent coating of a water-insoluble ionizable salt of a collagen
US3896806 *Dec 21, 1971Jul 29, 1975Ceskoslovenska Akademie VedImplant for directed infusion of biologically active substances
US4167045 *Aug 26, 1977Sep 11, 1979Interface Biomedical Laboratories Corp.Agar supported on dacron
US4329743 *Apr 27, 1979May 18, 1982College Of Medicine And Dentistry Of New JerseyPolylactic acid for surgical implant
US4361552 *Sep 26, 1980Nov 30, 1982Board Of Regents, The University Of Texas SystemWound dressing
US4411027 *Feb 23, 1982Oct 25, 1983University Of Medicine And Dentistry Of New JerseyBio-absorbable composite tissue scaffold
US4512038 *Apr 6, 1981Apr 23, 1985University Of Medicine And Dentistry Of New JerseyCarbon fiber, polylactic acid composites, fractured bones
US4512761 *Oct 6, 1983Apr 23, 1985Bentley Laboratories, Inc.Body implantable connector
US4584722 *May 10, 1983Apr 29, 1986Yeda Research And Development Co., Ltd.Pet core embedded in silicone rubber with biodegbadable polyglycolic acid sleeve
US4629459 *Dec 28, 1983Dec 16, 1986Shiley Inc.Alternate stent covering for tissue valves
US4759748 *Sep 22, 1986Jul 26, 1988Raychem CorporationGuiding catheter
US4772285 *Oct 30, 1986Sep 20, 1988The Board Of Trustees Of The Leland Stanford Junior UniversityCollagen coated soft tissue prostheses
US4820626 *Jun 6, 1985Apr 11, 1989Thomas Jefferson UniversityMethod of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
US4822361 *Dec 24, 1986Apr 18, 1989Sumitomo Electric Industries, Ltd.Microfibrous tubular polytetrafluoroethylene with collagen, heparin, albumin or chitosan distributed in tube wall
US4839215 *Jun 9, 1986Jun 13, 1989Ceramed CorporationFlexibility connected; prosthetics
US4865031 *Oct 3, 1988Sep 12, 1989Keeffe Paul J OFabric and method of use for treatment of scars
US4915893 *Jul 15, 1983Apr 10, 1990Medtronic, Inc.Method of preparing polyester filament material
US5037656 *Sep 8, 1989Aug 6, 1991Millipore CorporationPorous membrane having hydrophilic and cell growth promotions surface and process
US5098779 *Jun 25, 1990Mar 24, 1992W. L. Gore & Associates, Inc.Carvable implant material
US5110852 *Oct 27, 1988May 5, 1992Rijksuniversiteit Te GroningenFilament material polylactide mixtures
US5157111 *May 2, 1991Oct 20, 1992Pachence James MMethod of bonding collagen to fibers, particularly dacron
US5230693 *Jun 27, 1991Jul 27, 1993Thomas Jefferson UniversityImplantable prosthetic device for implantation into a human patient having a surface treated with microvascular endothelial cells
US5383897 *Dec 10, 1993Jan 24, 1995Shadyside HospitalMethod and apparatus for closing blood vessel punctures
US5447966 *Feb 8, 1994Sep 5, 1995United States Surgical CorporationTreating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin
US5542594 *Oct 6, 1993Aug 6, 1996United States Surgical CorporationFor driving surgical fasteners into body tissue
US5569239 *Aug 18, 1994Oct 29, 1996Rare Earth Medical, Inc.Photoreactive suturing of biological materials
US5665114 *Aug 12, 1994Sep 9, 1997Meadox Medicals, Inc.Tubular expanded polytetrafluoroethylene implantable prostheses
US5681657 *Jan 31, 1996Oct 28, 1997Rainer H. FreyBiocompatible porous hollow fiber and method of manufacture and use thereof
US5716660 *May 31, 1995Feb 10, 1998Meadox Medicals, Inc.Impregnating microvoids in prosthesis with solution of soluble, biocompatible, biodegradable material comprising extracellular matrix proteins, raising ph to precipitate in situ
US5795584 *Feb 7, 1995Aug 18, 1998United States Surgical CorporationPost-surgical anti-adhesion device
US5817272 *Jun 18, 1997Oct 6, 1998Rainer H. FreyProcess for making a biocompatible porous holllow fiber
US5863654 *Jun 18, 1997Jan 26, 1999Rainer H. FreyPolypropylene having a coating of carbon made from the dehydrochlorination of a graft polymer of the polypropylene and vinylidene chloride
US5891167 *Jun 19, 1996Apr 6, 1999United States Surgical CorporationCollagen coated gut suture
US5908427 *May 30, 1997Jun 1, 1999United States Surgical CorporationSurgical stapling apparatus and method
US5954748 *Jul 15, 1996Sep 21, 1999United States Surgical CorporationGelatin coated gut suture
US5964774 *Sep 12, 1997Oct 12, 1999United States Surgical CorporationSurgical stapling apparatus and method with surgical fabric
US5998024 *Sep 26, 1995Dec 7, 1999Rainer H. FreyPolyvinylidene chloride
US6045560 *Jun 17, 1996Apr 4, 2000United States Surgical CorporationSurgical stapling apparatus with biocompatible surgical fabric
US6129757 *May 18, 1998Oct 10, 2000Scimed Life SystemsImplantable members for receiving therapeutically useful compositions
US6273897Feb 29, 2000Aug 14, 2001Ethicon, Inc.Surgical bettress and surgical stapling apparatus
US6325810Jun 30, 1999Dec 4, 2001Ethicon, Inc.Foam buttress for stapling apparatus
US6387104Nov 12, 1999May 14, 2002Scimed Life Systems, Inc.Method and apparatus for endoscopic repair of the lower esophageal sphincter
US6391052Oct 29, 1997May 21, 2002Scimed Life Systems, Inc.Immersion in aqueous electrolytes; electrodeposition of coating on metal surface
US6837894Mar 26, 2002Jan 4, 2005Scimed Life Systems, Inc.Method and apparatus for endoscopic repair of the lower esophageal sphincter
US7614258Oct 19, 2006Nov 10, 2009C.R. Bard, Inc.Prosthetic repair fabric
US7900484Nov 5, 2009Mar 8, 2011C.R. Bard, Inc.Prosthetic repair fabric
US7918864Nov 19, 2004Apr 5, 2011Boston Scientific Scimed, Inc.Apparatus for endoscopic repair of the lower esophageal sphincter
US8100934 *Nov 14, 2002Jan 24, 2012Sofradim ProductionDevice for occlusion of a corporeal duct, in particular a varicose vein
US8460691Apr 23, 2010Jun 11, 2013Warsaw Orthopedic, Inc.Fenestrated wound repair scaffold
US8628543Feb 28, 2011Jan 14, 2014Boston Scientific Scimed, Inc.Method and apparatus for endoscopic repair of the lower esophageal sphincter
DE19517727C1 *May 15, 1995Apr 25, 1996Rainer H FreyBiocompatible polyolefin materials
DE19517754C1 *May 15, 1995Apr 25, 1996Rainer H FreyBiocompatible porous hollow polyolefin fibres used as exchange materials and semipermeable membranes
EP0000949A1 *Aug 25, 1978Mar 7, 1979Philip Nicholas SawyerCardiac and vascular prostheses and methods of making the same
EP0206025A2 *Jun 4, 1986Dec 30, 1986Thomas Jefferson UniversityCoating for prosthetic devices
EP0698395A1 *Apr 27, 1995Feb 28, 1996Meadox Medicals, Inc.Tubular polyetrafluoroethylene implantable prosthesis
EP1028672A1 Nov 5, 1998Aug 23, 2000Expandable Grafts PartnershipIntravascular stent and method for manufacturing an intravascular stent
WO1992000110A1 *Jun 21, 1991Dec 26, 1991Gore & AssCarvable implant material
Classifications
U.S. Classification606/151, 606/229, 623/921
International ClassificationA61L27/34, A61F2/00
Cooperative ClassificationA61F2/0063, A61L27/34, Y10S623/921
European ClassificationA61L27/34, A61F2/00H